Risk factor
Very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Target Price
The average target price of OMCL is 53 and suggests 43% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell